1. Home
  2. FBIZ vs MRVI Comparison

FBIZ vs MRVI Comparison

Compare FBIZ & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Business Financial Services Inc.

FBIZ

First Business Financial Services Inc.

HOLD

Current Price

$57.62

Market Cap

488.9M

Sector

Finance

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.40

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIZ
MRVI
Founded
1909
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
488.9M
472.8M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
FBIZ
MRVI
Price
$57.62
$3.40
Analyst Decision
Strong Buy
Buy
Analyst Count
4
4
Target Price
$65.00
$4.13
AVG Volume (30 Days)
36.2K
1.9M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
2.33%
N/A
EPS Growth
14.23
14.29
EPS
5.94
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
$15.69
$12.44
Revenue Next Year
$8.47
$7.90
P/E Ratio
$9.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.90
$1.70
52 Week High
$60.54
$4.11

Technical Indicators

Market Signals
Indicator
FBIZ
MRVI
Relative Strength Index (RSI) 62.65 60.33
Support Level $53.56 $3.25
Resistance Level $59.58 $3.99
Average True Range (ATR) 1.34 0.17
MACD 0.42 0.07
Stochastic Oscillator 76.63 81.08

Price Performance

Historical Comparison
FBIZ
MRVI

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products, including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically, all the business activity functioned through the region of the United States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: